
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ALBBY and 80,000+ other tickers.
See exactly how ALBBY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ALBBY and 80,000+ other tickers.
Alibaba Health Information Technology Limited, an investment holding entity based in Causeway Bay, Hong Kong, manages a diverse range of operations across Mainland China and Hong Kong. Its core business revolves around pharmaceutical retail, operating an extensive e-commerce platform for health-related goods, and delivering a broad spectrum of digital healthcare services. The company directly sells a wide array of health products, including prescription and over-the-counter medications, nutritional supplements, various medical devices, and contact lenses. These are distributed to both…
No recent news available.